AstraZeneca resumes U.S. COVID-19 vaccine trial and J&J prepares to do same next week

AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial as early…